Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1310488/000109181818000190/bfnh10182018form10qsept.htm
November 2021
June 2021
December 2020
October 2020
July 2020
July 2020
May 2020
April 2020
March 2017
March 2009
Document and Entity Information - shares | 9 Months Ended | |
---|---|---|
Sep. 30, 2018 | Oct. 24, 2018 | |
Document And Entity Information | ||
Entity Registrant Name | BIOFORCE NANOSCIENCES HOLDINGS, INC. | |
Entity Central Index Key | 0001310488 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Common Stock, Shares Outstanding | 76,300,163 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2018 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1310488/000109181818000190/bfnh10182018form10qsept.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Bioforce Nanosciences Holdings, Inc..
Bioforce Nanosciences Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Bioforce Nanosciences Holdings, Inc. provided additional information to their SEC Filing as exhibits
Ticker: BFNH
CIK: 1310488
Form Type: 10-Q Quarterly Report
Accession Number: 0001091818-18-000190
Submitted to the SEC: Wed Oct 24 2018 4:02:16 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Sunday, September 30, 2018
Industry: Laboratory Analytical Instruments